Skip to main content

Table 6 Impact of rehabilitation programme on respiratory symptoms and quality of life– including BreathingSpace patients MRC grade 1-2

From: Is a large scale community programme as effective as a community rehabilitation programme delivered in the setting of a clinical trial?

 

Randomised trial – community setting intervention group

BreathingSpace – all participants

  
 

n

Mean before-after difference

SD

n

Mean before-after difference

SD

Difference in mean before-after differences (95% CI)

P-value for difference in mean before-after differences

CRQ symptoms

        

Dyspnoea

74

0.29

1.18

481

0.61

1.25

0.32 (0.03, 0.62)

0.03*

Fatigue

75

0.58

1.12

481

0.48

1.22

−0.10 (−0.38, 0.18)

0.31

Emotion

74

0.39

0.98

481

0.36

1.15

−0.03 (−0.27, 0.22)

0.79

Mastery

75

0.36

1.08

481

0.32

1.20

−0.04 (−0.31, 0.23)

0.86

SF-36v2 domains

        

Physical functioning

79

0.87

17.6

438

5.47

20.1

4.61 (0.16, 9.06)

0.08

Role-physical

79

8.25

24.6

437

7.36

26.6

−0.9 (−7.04, 5.24)

0.57

Bodily pain

78

1.29

25.8

356

2.55

26.3

1.25 (−5.30, 7.80)

0.71

General health

77

3.93

15.7

337

3.29

16.5

−0.64 (−4.68, 3.40)

0.78

Vitality

79

8.15

16.8

345

6.75

20.5

−1.4 (−5.82, 3.03)

0.42

Social functioning

80

12.7

29.5

356

7.97

31.7

−4.69 (−12.16, 2.79)

0.11

Role-emotional

79

5.17

31.0

346

7.77

32.9

2.6 (−5.26, 10.46)

0.38

Mental health

80

5.81

15.7

351

4.65

18.7

−1.16 (−5.23, 2.92)

0.48

PCS (Physical component summary)

73

0.98

6.49

317

1.11

7.5

0.13 (−1.61, 1.87)

0.84

MCS (Mental component summary)

73

5.38

10.4

317

3.78

12.1

−1.59 (−4.39, 1.20)

0.24

SF-6D

72

0.014

0.10

308

0.029

0.11

0.015 (−0.011, 0.040)

0.30

EQ-5D-3 L

80

0.066

0.28

317

0.039

0.14

−0.027 (−0.090, 0.036)

0.42

  1. * significant at 5% level.